Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ABBV AbbVie	$189.50 -0.7%	$187.37	$163.63 ▼ $218.66	$334.34B	0.48	6.25 million shs	3.71 million shs
KO CocaCola	$71.19 +0.4%	$71.08	$60.62 ▼ $74.38	$307.11B	0.45	16.16 million shs	9.44 million shs
SPY SPDR S&P 500 ETF Trust	$625.34 +0.8%	$590.54	$481.80 ▼ $626.28	$640.42B	1	59.25 million shs	51.07 million shs
VZ Verizon Communications	$43.62 +0.1%	$43.23	$37.59 ▼ $47.36	$183.62B	0.37	20.12 million shs	10.30 million shs

A Guide To High-Short-Interest Stocks

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ABBV AbbVie	0.00%	+4.19%	+1.17%	+1.57%	+15.66%
KO CocaCola	0.00%	+1.09%	-0.28%	+1.90%	+12.41%
SPY SPDR S&P 500 ETF Trust	0.00%	+1.70%	+4.94%	+23.76%	+13.41%
VZ Verizon Communications	0.00%	+3.08%	+0.67%	+1.19%	+6.11%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ABBV AbbVie	4.9065 of 5 stars	3.4	5.0	3.3	3.9	2.8	1.7	1.3
KO CocaCola	4.2464 of 5 stars	2.5	3.0	3.3	0.8	3.0	2.5	1.3
SPY SPDR S&P 500 ETF Trust	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
VZ Verizon Communications	4.4491 of 5 stars	1.3	2.0	5.0	3.5	3.5	2.5	1.9

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ABBV AbbVie	2.81	Moderate Buy	$211.29	11.50% Upside
KO CocaCola	3.06	Buy	$76.27	7.13% Upside
SPY SPDR S&P 500 ETF Trust	2.75	Moderate Buy	$625.34	N/A
VZ Verizon Communications	2.59	Moderate Buy	$47.25	8.32% Upside

Current Analyst Ratings Breakdown

Latest SPY, VZ, ABBV, and KO Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
6/11/2025	ABBV AbbVie	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Hold	$205.00
6/9/2025	ABBV AbbVie	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Hold	$204.00
6/9/2025	KO CocaCola	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$81.00
5/14/2025	ABBV AbbVie	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Neutral	$210.00 ➝ $205.00
5/8/2025	ABBV AbbVie	BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold
4/30/2025	KO CocaCola	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$73.00 ➝ $76.00
4/30/2025	KO CocaCola	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$84.00 ➝ $86.00
4/29/2025	ABBV AbbVie	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$214.00 ➝ $216.00
4/28/2025	ABBV AbbVie	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$204.00 ➝ $205.00
4/28/2025	ABBV AbbVie	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$241.00 ➝ $250.00
4/28/2025	VZ Verizon Communications	Tigress Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$55.00 ➝ $56.00

(Data available from 7/5/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ABBV AbbVie	$56.33B	5.94	$14.94 per share	12.68	$1.90 per share	99.74
KO CocaCola	$47.06B	6.51	$3.14 per share	22.70	$6.12 per share	11.63
SPY SPDR S&P 500 ETF Trust	N/A	N/A	N/A	N/A	N/A	N/A
VZ Verizon Communications	$134.79B	1.36	$8.87 per share	4.92	$23.89 per share	1.83

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ABBV AbbVie	$4.28B	$2.35	80.64	13.56	1.26	7.31%	412.03%	13.11%	7/24/2025 (Estimated)
KO CocaCola	$10.63B	$2.50	28.48	22.32	3.74	23.00%	45.49%	12.18%	7/22/2025 (Estimated)
SPY SPDR S&P 500 ETF Trust	N/A	N/A	25.94	∞	N/A	N/A	N/A	N/A	N/A
VZ Verizon Communications	$17.51B	$4.20	10.39	8.98	3.23	13.14%	19.66%	5.13%	7/21/2025 (Estimated)

Latest SPY, VZ, ABBV, and KO Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
7/24/2025	Q2 2025	ABBV AbbVie	$3.24	N/A	N/A	N/A	$14.93 billion	N/A
7/22/2025	Q2 2025	KO CocaCola	$0.83	N/A	N/A	N/A	$12.55 billion	N/A
7/21/2025	Q2 2025	VZ Verizon Communications	$1.18	N/A	N/A	N/A	$33.47 billion	N/A
4/29/2025	Q1 2025	KO CocaCola	$0.71	$0.73	+$0.02	$0.77	$11.23 billion	$11.13 billion
4/25/2025	Q1 2025	ABBV AbbVie	$2.40	$2.46	+$0.06	$0.72	$12.91 billion	$13.34 billion
4/22/2025	Q1 2025 Pre Recorded	VZ Verizon Communications	$1.15	$1.19	+$0.04	$1.16	$33.31 billion	$33.50 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ABBV AbbVie	$6.56	3.46%	N/A	279.15%	53 Years
KO CocaCola	$2.04	2.87%	N/A	81.60%	64 Years
SPY SPDR S&P 500 ETF Trust	$7.16	1.14%	N/A	N/A	N/A
VZ Verizon Communications	$2.71	6.21%	N/A	64.52%	20 Years

Latest SPY, VZ, ABBV, and KO Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
6/20/2025	ABBV AbbVie	quarterly	$1.64	3.54%	7/15/2025	7/15/2025	8/15/2025
6/6/2025	VZ Verizon Communications	quarterly	$0.6775	6.22%	7/10/2025	7/10/2025	8/1/2025
5/1/2025	KO CocaCola	quarterly	$0.51	2.86%	6/13/2025	6/13/2025	7/1/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ABBV AbbVie	44.14	0.76	0.64
KO CocaCola	1.57	1.10	0.89
SPY SPDR S&P 500 ETF Trust	N/A	N/A	N/A
VZ Verizon Communications	1.19	0.61	0.58

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ABBV AbbVie	70.23%
KO CocaCola	70.26%
SPY SPDR S&P 500 ETF Trust	63.54%
VZ Verizon Communications	62.06%

Insider Ownership

Company	Insider Ownership
ABBV AbbVie	0.25%
KO CocaCola	0.97%
SPY SPDR S&P 500 ETF Trust	N/A
VZ Verizon Communications	0.10%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ABBV AbbVie	55,000	1.77 billion	1.76 billion	Optionable
KO CocaCola	69,700	4.30 billion	4.26 billion	Optionable
SPY SPDR S&P 500 ETF Trust	N/A	1.03 billion	N/A	Not Optionable
VZ Verizon Communications	99,600	4.22 billion	4.21 billion	Optionable

SPY, VZ, ABBV, and KO Headlines

Recent News About These Companies

Verizon (VZ) Gets a Buy from Raymond James

July 4 at 10:45 AM | theglobeandmail.com

Brookstone Capital Management Has $17.84 Million Stock Holdings in Verizon Communications Inc. (NYSE:VZ)

July 4 at 8:47 AM | marketbeat.com

Kintegral Advisory LLC Has $4.31 Million Stake in Verizon Communications Inc. (NYSE:VZ)

July 4 at 8:38 AM | marketbeat.com

Global Wealth Management Investment Advisory Inc. Has $6.09 Million Position in Verizon Communications Inc. (NYSE:VZ)

July 4 at 8:37 AM | marketbeat.com

Nichols & Pratt Advisers LLP MA Has $34.68 Million Position in Verizon Communications Inc. (NYSE:VZ)

July 4 at 8:28 AM | marketbeat.com

IFM Investors Pty Ltd Has $40.58 Million Holdings in Verizon Communications Inc. (NYSE:VZ)

July 4 at 8:02 AM | marketbeat.com

Verizon Communications Inc. (NYSE:VZ) Holdings Boosted by 44 Wealth Management LLC

July 4 at 7:28 AM | marketbeat.com

Avantax Planning Partners Inc. Has $9.19 Million Stock Position in Verizon Communications Inc. (NYSE:VZ)

July 4 at 7:19 AM | marketbeat.com

Calamos Advisors LLC Buys 8,495 Shares of Verizon Communications Inc. (NYSE:VZ)

July 4 at 7:18 AM | marketbeat.com

Conning Inc. Acquires 797,619 Shares of Verizon Communications Inc. (NYSE:VZ)

July 4 at 6:43 AM | marketbeat.com

Sterling Financial Planning Inc. Takes $289,000 Position in Verizon Communications Inc. (NYSE:VZ)

July 4 at 6:35 AM | marketbeat.com

Davidson Trust Co. Acquires 13,082 Shares of Verizon Communications Inc. (NYSE:VZ)

July 4 at 6:25 AM | marketbeat.com

Revisor Wealth Management LLC Makes New Investment in Verizon Communications Inc. (NYSE:VZ)

July 4 at 5:26 AM | marketbeat.com

Verizon Leaks Google Pixel's July 2025 Update: Here's What Includes

July 3 at 12:45 AM | msn.com

Verizon Denied $22 Million Tax Refund at Rhode Island High Court

July 3 at 12:45 AM | news.bloomberglaw.comN

Why Verizon Communications (VZ) is a Top Momentum Stock for the Long-Term

July 3 at 10:51 AM | zacks.com

North Capital Inc. Invests $690,000 in Verizon Communications Inc. (NYSE:VZ)

July 3 at 9:03 AM | marketbeat.com

Verizon Communications Inc. (NYSE:VZ) Shares Bought by D.A. Davidson & CO.

July 3 at 9:02 AM | marketbeat.com

Verizon Communications Inc. (NYSE:VZ) Shares Sold by Xcel Wealth Management LLC

July 3 at 8:27 AM | marketbeat.com

Mutual Advisors LLC Has $5.77 Million Stock Position in Verizon Communications Inc. (NYSE:VZ)

July 3 at 8:25 AM | marketbeat.com

ZWJ Investment Counsel Inc. Buys 41,989 Shares of Verizon Communications Inc. (NYSE:VZ)

July 3 at 7:56 AM | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

The Boring Is Beautiful Portfolio: 3 Stocks for a Worried World
By Jeffrey Neal Johnson | June 22, 2025
View The Boring Is Beautiful Portfolio: 3 Stocks for a Worried World
What to Expect From the Q2 Earnings Reporting Cycle
By Thomas Hughes | June 23, 2025
View What to Expect From the Q2 Earnings Reporting Cycle
These 3 Dividend Stocks Pay You to Stay Calm in Summer
By Chris Markoch | June 9, 2025
View These 3 Dividend Stocks Pay You to Stay Calm in Summer
Overheated Market? Analysts Watch These Red Flags
By Chris Markoch | June 20, 2025
View Overheated Market? Analysts Watch These Red Flags
S&P 500 All-Time Highs: 5 Catalysts Driving It Higher
By Thomas Hughes | June 30, 2025
View S&P 500 All-Time Highs: 5 Catalysts Driving It Higher

SPY, VZ, ABBV, and KO Company Descriptions

AbbVie NYSE:ABBV

$189.50 -1.25 (-0.66%)

Closing price 07/3/2025 03:58 PM Eastern

Extended Trading

$188.90 -0.60 (-0.32%)

As of 07/3/2025 04:58 PM Eastern

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; Ubrelvy for the acute treatment of migraine in adults; and Qulipta for episodic and chronic migraine. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; Janssen Biotech, Inc.; and Genentech, Inc., as well as collaboration with Tentarix Biotherapeutics, LP to develop conditionally-active and multi-specific biologics for oncology and immunology. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

CocaCola NYSE:KO

$71.19 +0.28 (+0.39%)

Closing price 07/3/2025 03:58 PM Eastern

Extended Trading

$71.19 +0.00 (+0.01%)

As of 07/3/2025 04:59 PM Eastern

The Coca-Cola Company, a beverage company, manufactures, markets, and sells various nonalcoholic beverages worldwide. The company provides sparkling soft drinks, sparkling flavors; water, sports, coffee, and tea; juice, value-added dairy, and plant-based beverages; and other beverages. It also offers beverage concentrates and syrups, as well as fountain syrups to fountain retailers, such as restaurants and convenience stores. The company sells its products under the Coca-Cola, Diet Coke/Coca-Cola Light, Coca-Cola Zero Sugar, caffeine free Diet Coke, Cherry Coke, Fanta Orange, Fanta Zero Orange, Fanta Zero Sugar, Fanta Apple, Sprite, Sprite Zero Sugar, Simply Orange, Simply Apple, Simply Grapefruit, Fresca, Schweppes, Thums Up, Aquarius, Ayataka, BODYARMOR, Ciel, Costa, Dasani, dogadan, FUZE TEA, Georgia, glacéau smartwater, glacéau vitaminwater, Gold Peak, Ice Dew, I LOHAS, Powerade, Topo Chico, AdeS, Del Valle, fairlife, innocent, Minute Maid, and Minute Maid Pulpy brands. It operates through a network of independent bottling partners, distributors, wholesalers, and retailers, as well as through bottling and distribution operators. The company was founded in 1886 and is headquartered in Atlanta, Georgia.

SPDR S&P 500 ETF Trust NYSEARCA:SPY

$625.34 +4.89 (+0.79%)

Closing price 07/3/2025 05:00 PM Eastern

Extended Trading

$625.05 -0.29 (-0.05%)

As of 07/3/2025 05:00 PM Eastern

SPDR S&P 500 ETF Trust (the Trust) is a unit investment trust. The Trust seeks to provide investment results that, before expenses, correspond generally to the price and yield performance of the S&P 500 Index (the Index). The Trust seeks to achieve this investment objective by holding a portfolio of the common stocks that are included in the Index (the Portfolio), with the weight of each stock in the Portfolio substantially corresponding to the weight of such stock in the Index. The Trust invests in a range of sectors, including pharmaceuticals; oil, gas and consumable fuels; technology hardware storage and peripherals; insurance; information technology (IT) services; healthcare providers and services; semiconductors and semiconductor equipment; hotels, restaurants and leisure, communications equipment; commercial services and supplies; road and rail; real estate management and development; containers and packaging; professional services, and paper and forest products.

Verizon Communications NYSE:VZ

$43.62 +0.03 (+0.07%)

Closing price 07/3/2025 03:58 PM Eastern

Extended Trading

$43.64 +0.02 (+0.05%)

As of 07/3/2025 04:59 PM Eastern

Verizon Communications Inc., through its subsidiaries, engages in the provision of communications, technology, information, and entertainment products and services to consumers, businesses, and governmental entities worldwide. It operates in two segments, Verizon Consumer Group (Consumer) and Verizon Business Group (Business). The Consumer segment provides wireless services across the wireless networks in the United States under the Verizon and TracFone brands and through wholesale and other arrangements; and fixed wireless access (FWA) broadband through its wireless networks, as well as related equipment and devices, such as smartphones, tablets, smart watches, and other wireless-enabled connected devices. The segment also offers wireline services in the Mid-Atlantic and Northeastern United States, as well as Washington D.C. through its fiber-optic network, Verizon Fios product portfolio, and a copper-based network. The Business segment provides wireless and wireline communications services and products, including FWA broadband, data, video and conferencing, corporate networking, security and managed network, local and long-distance voice, and network access services to deliver various IoT services and products to businesses, government customers, and wireless and wireline carriers in the United States and internationally. The company was formerly known as Bell Atlantic Corporation and changed its name to Verizon Communications Inc. in June 2000. Verizon Communications Inc. was incorporated in 1983 and is headquartered in New York, New York.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time